Wegovy Pill Arrives in UK: A New Era for Weight Loss?

The once-daily Wegovy weight-loss pill, containing semaglutide, has begun its rollout in UK pharmacies, with thousands of patients receiving their initial doses. This new medication is available for private prescription to individuals classified as overweight or obese, provided they also commit to a healthy diet and exercise regimen. While approved by the UK's medicines regulator on June 11, 2026, it is not yet accessible through the National Health Service (NHS).

This oral formulation of semaglutide offers a convenient alternative for those who prefer not to self-inject, including individuals nervous about needles or those who travel frequently. Clinical trials indicate significant weight loss, with participants losing between 14% and 17% of their body weight over 64 weeks. Common side effects are gastrointestinal, such as nausea and diarrhea, and patients are advised to report any adverse reactions through the yellow card scheme.

Amidst this launch, authorities have issued warnings regarding the dangers of counterfeit pills circulating online. Consumers are urged to be wary of websites offering medication at suspiciously low prices without a proper consultation, as these may supply fake or harmful products, or be fronts for fraud. The Wegovy pill costs approximately £2.30 per day on some multi-month plans, with prices varying by dose and treatment duration.